Submit Manuscript

Journal of Pharmacy and Allied Health Sciences

Year: 2012 | Volume: 2 | Issue: 1 | Page No.: 12-20
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Research Article

Synergistic Influence of Tetracycline on the Antibacterial Activities of Amoxicillin Against Resistant Bacteria

O.O. Olajuyigbe

ABSTRACT

In this study, the in vitro influence of antibacterial activity of amoxicillin and tetracycline on each other was investigated by macrobroth dilution and checkerboard assay methods. Each of the antibiotics as well as their combinations proved inhibitory against all the tested organisms with the exception of Acinetobacter calcoaceticus showing high level of resistance. The inhibition zones produced by the combination of tetracycline and amoxicillin with those obtained from each antibiotic showed synergistic interaction which is concentration dependent. The checkerboard assay results showed 87.5 synergy and 12.5% antagonism with a high reduction in the Minimum Inhibitory Concentrations (MICs) and a strong bactericidal activity against the test organisms. Results of macrobroth dilution and checkerboard assays are complementary and indicated a strong synergistic interaction between amoxicillin and tetracycline.
PDF Abstract XML References Citation
Received: November 05, 2011;   Accepted: February 15, 2012;   Published: March 20, 2012

INTRODUCTION

The changing antimicrobial sensitivity pattern of causative organisms has posed a therapeutic challenge in treating patients in the recent time. Unregulated provision of antibiotics, dispensing of insufficient doses, reduced adherence to complete dose regimens and the poor quality of the drug supply (Goossens et al., 2005; Blomberg et al., 2007; Cars et al., 2008), decreasing effectiveness of conventional antimicrobial drugs (Park et al., 2011) coupled with the overuse or misuse of antibiotics accelerating antibiotic resistance (Collignon et al., 2009; Love et al., 2011) and Extended Spectrum Beta Lactamases (ESBL) (Gururajan et al., 2011) has caused serious problems due to the rapid emergence of multidrug-resistant pathogens as well as creating a major challenge for the public health in the world (Zhang et al., 2011). Resulting from these challenges, antibiotic resistance threatens human health worldwide (Karou et al., 2009; Hogberg et al., 2010), affect treatment decisions, patient outcome, health care expenditure and public perceptions of health care delivery (Okeke et al., 2005; Sosa et al., 2010). Since there is a growing awareness of public health concerns associated with the emergence of drug-resistant strains of bacteria (Raghunath, 2008) and antibiotic resistance is currently involving most of the known classes of natural and synthetic antibiotics (Pednekar et al., 2011), there is an urgent need for antibiotics with novel scaffolds and mechanism of actions. In response to identifying alternative means to combat these situations, combination therapy or polypharmacy has been acknowledged.

Combination therapy or polypharmacy (Alam et al., 2011) which is the concurrent use of two or more medications in a single patient has increased progressively with increasing global population, progression of the existing infections, onset of new microbial infections and development of resistance in infectious agents. It is known to be superior to single modality therapy (Masoudzadeh and Khalilian, 2007), able to minimize side effects (Haidari et al., 2008) and may be more effective in the treatment of resistant infections. The mitigating factors may include proliferation of new antimicrobial agents thought to be better tolerated than previously available drugs, the increasing tendency to treat partial response by introducing additional agents and increased use of drugs to alleviate adverse effects accompanying use of existing anti-infective agents. However good it is by simplifying treatment and improve drug compliance by reducing the burden of taking multiple drugs (Chobanian et al., 2003; Mancia et al., 2007), the mechanistic basis of many drug-drug interactions is well established (Stockley, 2002). The drug-drug interactions can occur as a result of changes in pharmacodynamics and/or pharmacokinetics. A pharmacodynamic interaction occurs when drugs act on the same receptor, site of action, or physiologic system. A drug or substance that interferes with or accentuates the absorption, distribution, or elimination of a second drug produces a pharmacokinetic interaction. While some drug interactions are beneficial, others are clinically harmful and may eventually result in therapeutic failures.

To avoid unpleasant pharmacological and therapeutic actions related to drug-drug interactions (Rashidul Bari et al., 2000) and forestall therapeutic failures, development of bacterial resistance and increased cost of treatment often associated with the inept polypharmaceutical practices, researches in synergistic mechanisms of action for controlling microbial infections with reduced side effects becomes indispensable. Hence, since there is a lack of information on the interactions between amoxicillin and tetracycline and the effects of their combination against bacteria of clinical importance, this study was designed to investigate the influence these antibiotics could have on the antibacterial activity of one another.

MATERIALS AND METHODS

Bacterial strain: The bacteria used in this study included Bacillus cereus (ATCC 10702), Staphylococcus aureus (ATCC 6538), Salmonella typhi (ATCC 13311), Acinetobacter calcoaceticus UP, Klebsiella pneumoniae KZN, Proteus vulgaris KZN, Enterococcus faecalis KZN and Staphylococcus aureus OK2a. These organisms were obtained from the Department of Biochemistry and Microbiology, University of Fort Hare, Alice, South Africa. The antibacterial assays were carried out using Mueller Hinton II Agar (Biolab) and broth.

Antibiotics used in this study: Antibiotic powders of Amoxicillin (Duchefa) and Tetracycline hydrochloride (Duchefa) were used. Stock antibiotic solutions were prepared and dilutions made according to the CLSI (Clinical Laboratory Standardization Institute) method or manufacturer’s recommendations (NCCLS, 1997; Richard et al., 2007).

Antibiotic susceptibility testing: Agar diffusion method: Each of the isolates was standardized using colony suspension method. Each strain's suspension was matched with 0.5 McFarland standards to give a resultant concentration of 1.5x108 CFU mL-1. The antibiotic susceptibility testing was determined using the modified Kirby-Bauer diffusion technique (Cheesbrough, 2006) by swabbing the Mueller-Hinton Agar (MHA) (Oxoids UK) plates with the resultant saline suspension of each strain. Wells were then bored into the agar medium with heat sterilized 6 mm cork borer. The wells were filled with 100 μL of different concentrations (31.25, 62.5 and 125 μg mL-1) of each of the antibiotics taking care not to allow spillage of the solutions onto the surface of the agar. To determine the combinatorial effect of the antibiotics, different solutions containing combined concentrations (31.25, 62.5 and 125 μg mL-1) of tetracycline and amoxicillin were prepared and used. The plates were allowed to stand for at least 30 min before being incubated at 37°C for 24 h (BSAC, 2002). The determinations were done in duplicates. After 24 h of incubation, the plates were examined if there is any zone of incubation (Bauer et al., 1966). The diameter of the zone of inhibition produced by the antibiotic alone and its combination were measured and interpreted using the CLSI zone diameter interpretative standards (CLSI, 2008). Synergism was considered when combinations exhibited inhibition zones increment of 0.5 mm above those produced by the individual antibiotics (Ahmad and Aqil, 2007).

Determination of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC): The Minimum Inhibitory Concentrations (MICs) for the two antibiotics under study were determined in duplicate by the macrobroth dilution method in Meuller Hinton broth according to CLSI (Clinical Laboratory Standardization Institute) (Richard et al., 2007). To determine the MICs of each antibiotic, the concentrations used for each of the antibiotics (0.0019-500) μg mL-1 were prepared by serial dilution in Mueller Hinton broth. To determine their combinatorial effects, combinations of different concentrations used in the determination of the MICs of each of the antibiotics were used. The tubes were inoculated with 100 μL of each of the bacterial strains. Blank Mueller Hinton broth was used as negative control. The bacterial containing tubes were incubated aerobically at 37°C for 24 h. Each combination assay was performed two times. The MIC was defined as the lowest dilution that showed no growth in the Mueller Hinton broth. The MBC was defined as the lowest dilution that did not show growth on Mueller Hinton agar after subculturing from the lowest concentrations that showed no bacterial growth (Lorian, 1980).

Checkerboard assay: The range of drug concentration used in the checkerboard assay was such that the dilution range encompassed the MIC for each drug used in the analysis. The Fractional Inhibitory Concentration (FIC) was derived from the lowest concentrations of the two antibiotics in combination permitting no visible growth of the test organisms on the Mueller Hinton agar plates after an incubation for 24 h at 37°C (Mandal et al., 2004). FIC indices were calculated using the formula FIC index = (MIC of tetracycline in combination/MIC of tetracycline alone) + (MIC of amoxicillin in combination/MIC of amoxicillin alone). Synergism by the checkerboard method was defined as an FIC index of ≤1, additive effect was defined as an FIC index = 1, Indifference effect was defined as an FIC index of >1 and ≤4 and antagonism effect was defined as an FIC index of > 4 (Kamatou et al., 2006; Petersen et al., 2006). Concentrations within the FIC panel were such that the MIC of each antibiotic was in the middle of the range of concentrations tested but lower than the MICs of the respective antibiotics.

RESULTS

In this study, each of the antibiotics as well as their combinations proved inhibitory against all the tested organisms with the exception of Acinetobacter calcoaceticus that showed high level of resistance to these antibiotics at the concentrations used singly or in combinations in vitro (Table 1). The resistance exhibited by this isolate at the low concentration was corroborated by the result obtained with the minimum inhibitory and bactericidal concentrations (Table 2).

Table 1: Zones of inhibition resulting from each antibiotic alone and their combinations
Image for - Synergistic Influence of Tetracycline on the Antibacterial Activities of Amoxicillin Against Resistant Bacteria

Table 2: Minimum inhibitory and bactericidal concentration values for amoxicillin and tetracycline antibiotics
Image for - Synergistic Influence of Tetracycline on the Antibacterial Activities of Amoxicillin Against Resistant Bacteria

A comparison of the inhibition zones produced by the combination of tetracycline and amoxicillin with those obtained from each antibiotic showed there is synergistic interaction which is concentration dependent between the two antibiotics. With the exception of Acinetobacter calcoaceticus, inhibitory effects of the combined antibiotics were consistently higher than the inhibitory effects of the individual antibiotic. Staphylococcus aureus (ATCC 6538), Acinetobacter calcoaceticus UP and Staphylococcus aureus OK2a considered resistant to amoxicillin by having low MIC values were drastically inhibited by the combined antibiotics. While the MIC values for tetracycline ranged between 0.0305 and 125 μg mL-1, the MIC values of amoxicillin ranged between 0.061 and 250 μg mL-1. Although most of these bacterial isolates had higher MIC values in amoxicillin than in tetracycline, all the bacteria exhibited higher inhibition zones when tested against amoxicillin as compared to tetracycline.

The results of checkerboard assay combinations showed 87.5% synergy and 12.5% antagonism (Table 3). Synergistic interactions between tetracycline and amoxicillin were observed against Bacillus cereus (ATCC 10702), Staphylococcus aureus (ATCC 6538), Salmonella typhi (ATCC 13311), Acinetobacter calcoaceticus UP, Klebsiella pneumoniae KZN, Enterococcus faecalis KZN and Staphylococcus aureus OK2a (FIC indices of 0.132-0.625) while combinations against Proteus vulgaris KZN exhibited antagonistic interaction (FIC index of 4.25). Although synergy did not depend on the bacterial susceptibilities to each of the antibiotics when used separately but was observed for most of the strains, a high decrease in MIC and a strong bactericidal activity against these strains is of significant importance.

Table 3: Fractional inhibitory concentration values for the combination of amoxicillin and tetracycline antibiotics
Image for - Synergistic Influence of Tetracycline on the Antibacterial Activities of Amoxicillin Against Resistant Bacteria
FIC TET: Fractional inhibitory concentration of tetracycline alone, FIC AMX: Fractional inhibitory concentration of amoxicillin alone, FICI: Fractional inhibitory concentration indices

DISCUSSION

Amoxicillin is a broad-spectrum bacteriolytic antibiotic while tetracycline is a broad-spectrum bacteriostatic antibiotic. They are widely used to treat community and healthcare-associated infections. The emergence and dissemination of antimicrobial resistance to these antibiotics represents a significant threat to human health (Woodford and Livermore, 2009). For these antibiotics, numerous resistance mechanisms including expression of drug-destroying enzymes such as β-lactamases (Paterson and Bonomo, 2005), altered drug targets such as conformational changes in penicillin-binding proteins (PBPs), decreased bacterial permeability, increased drug efflux (Wright, 2005; Piddock, 2006; Chen et al., 2011), ribosomal protection and tetracycline modification (Roberts, 2003, 2005) have been described. Discovering a combination therapy capable of preventing or inhibiting the expression of these different mechanisms of resistance will be a giant stride towards effective chemotherapy using these antibacterial agents.

In this study, the impact of each antibiotic on each organism is specific and differs from organism to organism. Amoxicillin and tetracycline showed a powerful bactericidal activity to most of the test organisms and their combinations have apparent synergistic effects. The synergistic effect may be due to the formation of certain complexes which becomes effective in inhibiting the affected microorganisms either by inhibiting the bacterial protein and cell wall synthesis, by causing its lyses or death or by attacking different target sites apart from their known target sites of actions. Bliss (1939) and Greco et al. (1995) indicated that combinations of drugs may inhibit bacterial growth in complex ways, deviating from the neutral situation expected when they do not interact. Hence, the double attack of both agents on different target sites of the bacteria could have theoretically lead to either an additive or a synergistic effect (Esimone et al., 2006) as obtained in this study.

The synergistic interactions resulting in drastic increase in the MICs of the test antibiotics are significant. The ability of these combinations to inhibit Gram-negative and Gram-positive as well as those considered resistant to amoxicillin to a great extent showed that combined therapy of tetracycline and amoxicillin against infectious agents could be more effective than their monotherapy and amoxicillin-clavulanic acid as well as killing pathogens before resistance development. While combined antibiotic therapy has been shown to delay the emergence of bacteria resistance, the synergistic effects are often known to surpass their individual inhibitory activity. In agreement with the report of Sato et al. (2004), the combination of the two agents showed significant synergism because the test organisms had a high MIC to at least one of the agents. The significant increase in the MICs of the antibiotics in the combined state showed that the combination of the two antibiotics is a veritable source of potential resistance modifying agents (Dickson et al., 2006). Hence, while new therapy can be developed by combining synthetic, semi synthetic and natural drugs in pharmaceutical formulations (Kadam et al., 2010), combining the two antibiotics while reducing their doses and the risk of dose-related toxicity will result in enhanced efficiency (Salam et al., 2009).

Although, there is a dearth of information on the interaction between amoxicillin and tetracycline, interactions between these antibiotics and other chemotherapeutic agents have been reported. Drug-drug interactions between amoxicillin (Wood and Deeble, 1993; Soto et al., 1993; Bandrowsky et al., 1996) as well as amoxicillin-clavulanic acid (Penning-van Beest et al., 2001) with warfarin have been reported in vivo. Most drug interactions of tetracycline are pharmacokinetic and reflect changes in their absorption and elimination or the absorption and elimination of other agents. The plasma concentrations of tetracycline are markedly reduced (30 to 90%) with the concurrent administration of products containing divalent, trivalent and multivalent cations. Tetracycline lowers plasma concentrations of atovaquone and increases that of quinine when concomitantly administered against Plasmodium falciparum (Pai et al., 2006). Vancomycin combined with cephalosporins and penicillins has been shown to synergistically inhibit a number of gram-negative bacilli (Donabedian and Andriole, 1977). Darras-Joly et al. (1996) indicated synergy between ß-lactam antibiotics and gentamicin against Streptococcus pneumonia. Olsson et al. (1961) reported antagonistic interactions for penicillin combined with tetracycline against pneumococci, Chan et al. (2007) reported that phenothiazines interact synergistically with amoxicillin against Burkholderia pseudomallei.

In conclusion, these in vitro data still need to be validated by assessing the clinical performances of these combinations. These findings could also prove to be a promising alternative in the treatment of patients for whom existing antimicrobial treatment fails. Despite the lack of knowledge for the underlying mechanism of the synergistic effect of amoxicillin and tetracycline combinations, there is a great potential for use of such combinations against infectious pathogens since it may be able to make some untreatable resistant infections treatable at the recommended dosages that are often marginally effective against resistant strains when used alone. A wider study with increase in the number of drugs and clinical isolates are necessary to establish the mode of action and the mechanism of synergy which is fundamental to the development of a more effective pharmacological agent.

REFERENCES

  1. Salam, M.A., M.A. Baki, A.T.M. Zafrul Azam, M.S. Amran, F.M. Amjad, B. Rokaya and M.A. Hossain, 2009. In vitro and in vivo effects of glipizide and gliclazide on the protein binding, plasma concentration and serum glucose, cholesterol and creatinine levels of ibuprofen. J. Pharmacol. Toxicol., 4: 307-313.
    CrossRefDirect Link
  2. Ahmad, I. and F. Aqil, 2007. In vitro efficacy of bioactive extracts of 15 medicinal plants against ESβL-producing multidrug-resistant enteric bacteria. Microbiol. Res., 162: 264-275.
    CrossRefDirect Link
  3. Alam, K.D., M.K. Hosain, S. Kabir, R.M.A.A. Chowdhury and S. Mahjabeen et al., 2011. In vitro binding chemistry of amlodipine besylate (calcium channel blocker) and atorvastatin calcium (HMG-CoA reductase inhibitor) to serum albumin and their mutual effect to displace each other from the binding site. Am. J. Drug Discovery Dev., 1: 220-230.
    CrossRefDirect Link
  4. Bandrowsky, T., A.A. Vorono, T.J. Borris and H.W. Marcantoni, 1996. Amoxicillin-related postextraction bleeding in an anticoagulated patient with tranexamic acid rinses. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol., 82: 610-612.
    CrossRefDirect Link
  5. BSAC, 2002. Disc diffusion methods for antimicrobial susceptibility testing. Br. Soc. Antimicrob. Chemother., 2: 1-46.
  6. Rashidul Bari, A.H.M., A.T.M. Zafrul Azam, M.S. Amran and M.A. Hossain, 2000. In vivo effects of ibuprofen and naproxen on the plasma concentration of diltiazem in rabbits. Pak. J. Biol. Sci., 3: 555-557.
    CrossRefDirect Link
  7. Bauer, A.W., W.M.M. Kirby, J.C. Sherris and M. Turck, 1966. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol., 45: 493-496.
    CrossRefPubMedDirect Link
  8. Bliss, C.I., 1939. The toxicity of poisons applied jointly. Ann. Applied Biol., 26: 585-615.
    CrossRefDirect Link
  9. Blomberg, B., K.P. Manji, W.K. Urassa, B.S. Tamim and D.S.M. Mwakagile et al., 2007. Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: A prospective cohort study. BMC Infect. Dis., Vol. 7.
    CrossRefDirect Link
  10. Cars, O., L.D. Hogberg, M. Murray, O. Nordberg and S. Sivaraman et al., 2008. Meeting the challenge of antibiotic resistance. Br. Med. J., 337: 726-728.
    Direct Link
  11. Chan, Y.Y., Y.M. Ong and K.L. Chua, 2007. Synergistic Interaction between Phenothiazines and Antimicrobial Agents against Burkholderia pseudomallei. Antimicrobial Agents Chemother., 51: 623-630.
    CrossRef
  12. Cheesbrough, M., 2006. District Laboratory Practice in Tropical Countries, Volume 2. 2nd Edn., Cambridge University Press, UK., ISBN-13: 9780521676311, pp: 64-68, 136-142.
  13. Chen, C.M., M. Huang, H.F. Chen, S.C. Ke, C.R. Li, J.H. Wang and L.T. Wu, 2011. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital. BMC Microbiol., Vol. 11.
    CrossRefDirect Link
  14. Chobanian, A.V., G.L. Bakris, H.R. Black, W.C. Cushman and L.A. Green et al., 2003. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: The JNC 7 report. J. Am. Med. Assoc., 289: 2560-2571.
    CrossRefPubMedDirect Link
  15. CLSI., 2008. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement. 18th Edn., Clinical and Laboratory Standard Institute, USA., ISBN-13: 9781562386535, Pages: 181.
  16. Collignon, P., P.J. Howers, T.M. Chiller, A. Aidara-Kane and F.M. Aarestrup, 2009. World health organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin. Infect. Dis., 49: 132-141.
    CrossRefPubMedDirect Link
  17. Darras-Joly, C., J.P. Bedos, C. Sauve, P. Moine, E. Vallee, C. Carbon and E. Azoulay-Dupuis, 1996. Synergy between amoxicillin and gentamycin in combination against a highly penicillin-resistant and -tolearant strain of Streptococcus pneumonia in a mouse pneumonia model. Antimicrob. Agents Chemother., 40: 2147-2151.
    Direct Link
  18. Dickson, R.A., P.J. Houghton, P.J. Hylands and S. Gibbons, 2006. Antimicrobial, resistance-modifying effects, antioxidant and free radical scavenging activities of Mezoneuron benthamianum Baill, Securinega virosa Roxb and willd and Microglossa pyrifolia Lam. Phytother. Res., 20: 41-45.
    CrossRef
  19. Donabedian, H. and V.T. Andriole, 1977. Synergy of vancomycin with penicillins and cephalosporins against pseudomonas, klebsiella and serratia. Yale J. Biol. Med., 50: 165-176.
    PubMedDirect Link
  20. Esimone, C.O., I.R. Iroha, E.C. Ibezim, C.O. Okeh and E.M. Okpana, 2006. In vitro evaluation of the interaction between tea extracts and penicillin G against Staphylococcus aureus. Afr. J. Biotechnol., 5: 1082-1086.
  21. Goossens, H., M. Ferech, R.V. Stichele and M. Elseviers, 2005. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet, 365: 579-587.
    CrossRef
  22. Gururajan, G., K.A. Kaliyaperumal and B. Ramasamy, 2011. Prevalence of extended spectrum β lactamases in uropathogenic Escherichia coli and Klebsiella species in a Chennai suburban tertiary care hospital and its antibiogram pattern. Res. J. Microbiol., 6: 796-804.
    CrossRefDirect Link
  23. Greco, W.R., G. Bravo and J.C. Parsons, 1995. The search for synergy: A critical review from a response surface perspective. Pharmacol. Rev., 47: 331-385.
    PubMedDirect Link
  24. Haidari, F., M.R. Rashidi, S.A. Keshavarz, S.A. Mahboob, M.R. Eshraghian and M.M. Shahi, 2008. Effects of onion on serum uric acid levels and hepatic xanthine dehydrogenase/xanthine oxidase activities in hyperuricemic rats. Pak. J. Biol. Sci., 11: 1779-1784.
    CrossRefPubMedDirect Link
  25. Hogberg, L.D., A. Heddini and O. Cars, 2010. The global need for effective antibiotics: Challenges and recent advances. Trends Pharmacol. Sci., 31: 509-515.
    PubMed
  26. Kadam, N.M., H.S. Chaudhari, J.K. Parikh, V.S. Modi, S.U. Kokil and V.M. Balaramnavar, 2010. De novo combination therapy in retroviral infection. Int. J. Virol., 6: 219-223.
  27. Kamatou, G.P.P., A.M. Viljoen, S.F. van Vuuren and R.L. van Zyl, 2006. In vitro evidence of antimicrobial synergy between Salvia chamelaeagnea and Leonotis leonurus. South Afr. J. Bot., 72: 634-636.
  28. Karou, S.D., D.P. Ilboudo, W.M.C. Nadembega, Y. Ameyapoh and D. Ouermi et al., 2009. Antibiotic resistance in urinary tract bacteria in ouagadougou. Pak. J. Biol. Sci., 12: 712-716.
    CrossRefPubMedDirect Link
  29. Lorian, V., 1980. Antibiotics in Laboratory Medicine. Williams and Wilkins, Baltimore, MD., USA., pp: 95-98.
  30. Love, D.C., M.F. Davis, A. Bassett, A. Gunther and K.E. Nachman, 2011. Dose imprecision and resistance: Free-choice medicated feeds in industrial food animal production in the United States. Environ. Health Perspect., 119: 279-283.
    Direct Link
  31. Mancia, G., G. de Backer, A. Dominiczak, R. Cifkova and R. Fagard et al., 2007. ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J. Hypertens., 25: 1751-1762.
  32. Mandal, S., M.D. Mandal and N.K. Pal, 2004. Evaluation of combination effect of ciprofloxacin and cefazolin against Salmonella enteric serovar typhi isolates by in vitro methods. Calicut Med. J., 2: e2-e2.
    Direct Link
  33. Masoudzadeh, A. and A.R. Khalilian, 2007. Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. Pak. J. Biol. Sci., 10: 4287-4290.
    CrossRefPubMedDirect Link
  34. NCCLS, 1997. Methods for Antimicrobial Susceptibility Testing for Bacteria That Grow Aerobically. 3rd Edn., National Committee for Clinical Laboratory Standards, Villanova, PA., USA.
  35. Okeke, I.N., R. Laxmaninarayan, Z.A. Bhutta, A.G. Duse and P. Jenkins et al., 2005. Antimicrobial resistance in developing countries. Part I: Recent trends and current status. Lancet Infect. Dis., 5: 481-493.
    CrossRefPubMedDirect Link
  36. Olsson, R.A., J.C. Kirby and M.J. Romansky, 1961. Pneumococcal meningitis in the adult. Clinical, therapeutic and prognostic aspects in forty-three patients. Ann. Int. Med., 55: 545-549.
    PubMedDirect Link
  37. Pai, M.P., K.M. Momary and K.A. Rodvold, 2006. Antibiotic drug interactions. Med. Clin. N. Am., 90: 1223-1225.
  38. Park, S.C., Y. Park and K.S. Hahm, 2011. The role of antimicrobial peptides in preventing multidrug resistant bacterial infections and biofilm formation. Int. J. Mol. Sci., 12: 5971-5992.
    CrossRef
  39. Paterson, D.L. and R.A. Bonomo, 2005. Extended-spectrum β-lactamases: A clinical update. Clin. Microbiol. Rev., 18: 657-686.
    CrossRefPubMedDirect Link
  40. Pednekar, P., R. Jain and G. Mahajan, 2011. Anti-infective potential of hot-spring bacteria. J. Glob. Infect. Dis., 3: 241-245.
    CrossRef
  41. Penning-van Beest, F.J., E. van Meegen, F.R. Rosendaal and B.H. Stricker, 2001. Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin. Pharmacol. Ther., 69: 451-457.
    Direct Link
  42. Petersen, P.J., P. Labthavikul, C.H. Jones and P.A. Bradford, 2006. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J. Antimicrob. Chemother., 57: 573-576.
    Direct Link
  43. Piddock, L.J., 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev., 19: 382-402.
    PubMed
  44. Raghunath, D., 2008. Emerging antibiotic resistance in bacteria with special reference to India. J. Biosci., 33: 593-603.
    Direct Link
  45. Richard, S., S.M. Lynn and C.G. Avery, 2007. Antimicrobial Susceptibility Testing Protocols. CRC Press, New York.
  46. Roberts, M.C., 2003. Acquired tetracycline and macrolide-lincosamides-streptogramin resistance in anaerobes. Anaerobe, 9: 63-69.
    PubMed
  47. Roberts, M.C., 2005. Update on acquired tetracycline resistance genes. FEMS Microbiol. Lett., 245: 195-203.
    PubMed
  48. Sato, Y., H. Shibata, T. Arai, A. Yamamoto, Y. Okimura, N. Arakaki and Higuti, 2004. Variation in synergistic activity by flavonone and its related compounds on the increased susceptibility of various strains of methicillin-resistant Staphylococcus aureus to βlactam antibiotics. Int. J. Antimicrob. Agents., 24: 226-233.
  49. Soto, J., J.A. Sacristan, M.J. Alsar, C. Fernandez-Viadero and R. Verduga, 1993. Probable acenocoumarol-amoxycillin interaction. Acta Haematol., 90: 195-197.
  50. Sosa, A.J., D.K. Byarugaba, C.F. Amabile-Cuevas, P.R. Hsueh, S. Kariuki and I.N. Okeke, 2010. Antimicrobial Resistance in Developing Countries. Springer, New York.
  51. Stockley, I.H., 2002. Drug Interactions. The Pharmaceutical Press, London.
  52. Wood, G.D. and T. Deeble, 1993. Warfarin: Dangers with antibiotics. Dent Update, 20: 352-353.
  53. Woodford, N. and D.M. Livermore, 2009. Infections caused by Gram-positive bacteria: A review of the global challenge. J. Infect., 59: S4-S16.
    Direct Link
  54. Wright, G.D., 2005. Bacterial resistance to antibiotics: Enzymatic degradation and modification. Adv. Drug Deliv. Rev., 57: 1451-1470.
    CrossRefDirect Link
  55. Zhang, T., X.X. Zhang and L. Ye, 2011. Plasmid metagenome reveals high levels of antibiotic resistance genes and mobile genetic elements in activated sludge. PLoS One, Vol. 6, No. 10.
    CrossRefDirect Link

Related Articles

In vitro Binding Chemistry of Amlodipine Besylate (Calcium Channel Blocker) and Atorvastatin Calcium (HMG-CoA Reductase Inhibitor) to Serum Albumin and their Mutual Effect to Displace Each Other from the Binding Site
Prevalence of Extended Spectrum Beta Lactamases in Uropathogenic Escherichia coli and Klebsiella Species in a Chennai Suburban Tertiary Care Hospital and its Antibiogram Pattern
Effects of Onion on Serum Uric Acid Levels and Hepatic Xanthine Dehydrogenase/Xanthine Oxidase Activities in Hyperuricemic Rats
Antibiotic Resistance in Urinary Tract Bacteria in Ouagadougou
Comparative Study of Clozapine, Electroshock and the Combination of ECT with Clozapine in Treatment-Resistant Schizophrenic Patients

Leave a Comment

Your email address will not be published. Required fields are marked *